Daxxify represents a notable advance in neurotoxin therapy largely because of its peptide-based technology. Unlike traditional botulinum toxin formulations that rely solely on the core neurotoxin protein and human serum albumin for stabilization, Daxxify uses a proprietary peptide excipient to stabilize the active molecule.